J. Onishi

发表

Illumina sequencing of the V4 hypervariable region 16S rRNA gene reveals extensive changes in bacterial communities in the cecum following carbohydrate oral infusion and development of early-stage acute laminitis in the horse.

S. Eades, C. Reinemeyer, Michael Moreau, 2014, Veterinary microbiology.

Can Dietary Fatty Acids Affect the COVID-19 Infection Outcome in Vulnerable Populations?

S. Shapses, M. Häggblom, J. Onishi, 2020, mBio.

Green Tea Polyphenols Modify the Gut Microbiome in db/db Mice as Co‐Abundance Groups Correlating with the Blood Glucose Lowering Effect

N. Ajami, M. C. Ross, Liping Zhao, 2019, Molecular nutrition & food research.

Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-D-glucan synthase

J. Onishi, C. Douglas, J. Marrinan, 1994, Antimicrobial Agents and Chemotherapy.

Geranylgeranyltransferase I of Candida albicans: Null Mutants or Enzyme Inhibitors Produce Unexpected Phenotypes

J. Williamson, J. Onishi, M. Kurtz, 2000, Journal of bacteriology.

L-657,398, a novel antifungal agent: fermentation, isolation, structural elucidation and biological properties.

G. Garrity, R. Schwartz, O. Hensens, 1988, The Journal of antibiotics.

The isolation and structure elucidation of zaragozic acid C, a novel potent squalene synthase inhibitor.

K. Wilson, F. Peláez, G. Bills, 1992 .

Discovery of Novel Antifungal (1,3)-β-d-Glucan Synthase Inhibitors

R. Schwartz, F. Vicente, A. Cabello, 2000, Antimicrobial Agents and Chemotherapy.

Carbazate as a glycine bioisostere in restricticin.

A. Patchett, K. Wilson, K. Bartizal, 1996, The Journal of antibiotics.

Pramanicin, a novel antimicrobial agent from a fungal fermentation

R. Schwartz, G. Helms, K. Wilson, 1994 .

Antifungal spectrum, in vivo efficacy, and structure-activity relationship of ilicicolin h.

V. Hornak, C. Gill, Sheo B. Singh, 2012, ACS medicinal chemistry letters.

Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-beta-D-glucan synthase inhibitors

A. Mitchell, K. Bartizal, J. Onishi, 1997, Antimicrobial agents and chemotherapy.

Rhodopseudomonas sphaeroides membranes: alterations in phospholipid composition in aerobically and phototrophically grown cells

R. Niederman, J. Onishi, 1982, Journal of bacteriology.

Antimicrobial activity of viridiofungins.

F. Vicente, F. Peláez, J. Onishi, 1997, The Journal of antibiotics.

Increased antifungal activity of L-733,560, a water-soluble, semisynthetic pneumocandin, is due to enhanced inhibition of cell wall synthesis

J. Balkovec, J. Onishi, C. Douglas, 1994, Antimicrobial Agents and Chemotherapy.

Mode of Action of β‐Lactone 1233A in Candida albicans

G. Garrity, R. Fromtling, B. Pelak, 1988 .

Mode Of Action of L‐660,631 in Candida albicans

G. Garrity, R. Fromtling, B. Pelak, 1988 .

Intestinal bacterial overgrowth includes potential pathogens in the carbohydrate overload models of equine acute laminitis.

S. Eades, M. Häggblom, Joong-Wook Park, 2012, Veterinary microbiology.

Chronic laminitis is associated with potential bacterial pathogens in the laminae.

M. Häggblom, Joong-Wook Park, M. N. Fugaro, 2012, Veterinary microbiology.

Bacterial communities in the small intestine respond differently to those in the caecum and colon in mice fed low- and high-fat diets.

M. Häggblom, J. Storch, Michael Moreau, 2017, Microbiology.

A Novel Staphylococcus aureus Vaccine: Iron Surface Determinant B Induces Rapid Antibody Responses in Rhesus Macaques and Specific Increased Survival in a Murine S. aureus Sepsis Model

Charles Y. Tan, W. Mcclements, K. Jansen, 2006, Infection and Immunity.

Restricticin, a novel glycine-containing antifungal agent.

R. Schwartz, K. Wilson, R. Fromtling, 1991, The Journal of antibiotics.

Isolation and Structural Determination of Enfumafungin, a Triterpene Glycoside Antifungal Agent That Is a Specific Inhibitor of Glucan Synthesis

Scott K. Smith, R. Schwartz, F. Vicente, 2000 .

Enzymatic deglycosylation of enfumafungin, a triterpene glycoside natural product, and its chemically synthesized analogues

Z. Guan, J. Onishi, Aileen Bouffard, 2001 .

Antimicrobial activity of ergokonin A from Trichoderma longibrachiatum

A. Tsipouras, A. Cabello, K. Wilson, 2001, Journal of applied microbiology.

Arundifungin, a novel antifungal compound produced by fungi: biological activity and taxonomy of the producing organisms

R. Schwartz, F. Vicente, A. Cabello, 2001, International microbiology : the official journal of the Spanish Society for Microbiology.

The lack of antifungal activity by avermectin B1a.

J. Onishi, T. Miller, 1985, The Journal of antibiotics.

Chronic laminitis is associated with potential bacterial pathogens in the laminae.

M. Häggblom, Joong-Wook Park, M. N. Fugaro, 2012, Veterinary microbiology.

The discovery of enfumafungin, a novel antifungal compound produced by an endophytic Hormonema species biological activity and taxonomy of the producing organisms.

R. Schwartz, L. Kong, F. Vicente, 2000, Systematic and applied microbiology.

Intestinal bacterial overgrowth includes potential pathogens in the carbohydrate overload models of equine acute laminitis.

S. Eades, M. Häggblom, Joong-Wook Park, 2012, Veterinary microbiology.